We are super excited to announce that the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) will support Choice in the preclinical testing of the device. Soon we will start with the finalization of the protocol & tests are expected to start end of this year.

NIH employs five broad decision criteria in its funding policy. First, ensure the highest quality of scientific research by employing an arduous peer review process. Second, seize opportunities that have the greatest potential to yield new knowledge and that will lead to better prevention and treatment of disease. Third, maintain a diverse research portfolio in order to capitalize on major discoveries in a variety of fields such as cell biology, genetics, physics, engineering, and computer science. Fourth, address public health needs according to the disease burden (e.g., prevalence and mortality). And fifth, construct and support the scientific infrastructure (e.g., well-equipped laboratories and safe research facilities) necessary to conduct research (source: NIH).

We are honoured to be chosen on the basis of these requirements. The NIH has one of the proudest records in medical research. We are ready to add to that!